Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(TSX: SVA )

0.2000 +0.0050 (+2.56%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SVA

< Previous 1 2 Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines
Via JCN Newswire
Exposures COVID-19
ROSEN, A LEADING LAW FIRM, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Indonesia's Bio Farma ready to produce 'IndoVac' Covid-19 vaccines
Via ACN Newswire
Exposures COVID-19
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
Via ACN Newswire
Exposures COVID-19
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Lawsuit Alleges Securities Laws Violations by 1Globe Capital LLC
San Diego, CA -- (SBWIRE) -- 09/02/2022 -- An investor, who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ:SVA), filed a lawsuit over alleged Securities Laws violations by 1Globe Capital... 
Via SBWire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SINOVAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
From The Rosen Law Firm, P.A.
Via Business Wire
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
From Sinovac Biotech Ltd.
Via Business Wire
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022
Upgrades 
Via Benzinga
SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Polio Vaccine Prequalified by WHO
From SINOVAC Biotech Ltd.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.